Elhabashy, Sameh
Moriyama, Michiko
Mahmoud, Eman Ibrahim El-Desoki
Eysa, Basem
Funding for this research was provided by:
Cairo University
Article History
Received: 19 April 2023
Accepted: 14 March 2024
First Online: 2 April 2024
Declarations
:
: This study was registered with Clinical Trials.gov (Registration # NCT05721664) on 10/02/2023 and approved by the Research Ethics Committee for Human Subject Research at NHTMRI-IRB, Egypt (approval # 33/22). Participation in this study was entirely voluntary, and a written informed consent was obtained before the commencement of the study, the authors are attesting that all participants were aware of the study’s purpose, risks, and potential benefits before providing written consent. Participants had the right to withdraw from the study at any time without any repercussions on their professional evaluations, while still receiving the traditional routine education as usual. Even though the control group did not receive the intervention being studied, they still received equitable education to ensure fairness, and no expected harm was verified. Also, we intend to provide the EBP training programme to the control group if the intervention proves to be effective, thus ensuring equal treatment for all participants in the study. The study was conducted with the participants’ rights and safety protected by adhering to local Egypt laws and all methods were carried out in accordance with relevant guidelines and regulations of the Declaration of Helsinki. Every participant received a unique identification number, which protected their anonymity. Confidentiality was also confirmed.
: Not applicable.
: The authors declare no competing interests.